Joseph Hammang, Ph.D., Partner at Vital Transformation Healthcare Consultancy, says some of the backlash against accelerated approval comes from those not informed on the process; Hammang also says impacts from the Inflation Reduction Act have some...
Joseph Hammang, Ph.D., Partner at Vital Transformation Healthcare Consultancy, says some of the backlash against accelerated approval comes from those not informed on the process; Hammang also says impacts from the Inflation Reduction Act have some investors wary; and The Wall Street Journal has a new article stating generic drugs should be cheaper, but insurers are charging thousands of dollars for them.